NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 15,600 shares, an increase of 23.8% from the August 15th total of 12,600 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily volume of 47,600 shares, the days-to-cover ratio is presently 0.3 days.
NEXGEL Price Performance
Shares of NEXGEL stock traded down $0.05 during mid-day trading on Tuesday, reaching $2.65. 16,086 shares of the stock were exchanged, compared to its average volume of 29,280. NEXGEL has a fifty-two week low of $1.46 and a fifty-two week high of $3.24. The company has a market cap of $16.50 million, a price-to-earnings ratio of -4.82 and a beta of 0.77. The firm has a 50-day simple moving average of $2.66 and a 200 day simple moving average of $2.44. The company has a current ratio of 1.36, a quick ratio of 0.81 and a debt-to-equity ratio of 0.22.
NEXGEL (NASDAQ:NXGL – Get Free Report) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.14) earnings per share for the quarter. NEXGEL had a negative return on equity of 64.21% and a negative net margin of 67.80%. The firm had revenue of $1.44 million for the quarter.
Institutional Investors Weigh In On NEXGEL
About NEXGEL
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Read More
- Five stocks we like better than NEXGEL
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Stock Market Sectors: What Are They and How Many Are There?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What Does Downgrade Mean in Investing?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.